Michele Washko

President & CEO

Michele Washko is President and CEO of LSG Investments. She brings to LSG nearly 25 years’ experience in healthcare commercialization, finance and innovation. She served as V.P., Strategic Services, for the Life Sciences Greenhouse from 2005 until 2015, when she departed for Geisinger Health System’s Institute for Advanced Application. Ms. Washko went on to found Life Science Innovations, a boutique consulting firm, in 2017 and to serve as COO, then CEO, of Respana Therapeutics, Inc. Ms. Washko holds a Bachelor of Arts degree from Emory University, an MBA from Penn State University, and a certificate in Executive Leadership from M.I.T.

@lifesciinvestor